Analyst Gregg Gilbert works at BAML and is focused on the Healthcare sector with 463 price targets and ratings documented since 2013 spanning on 25 stocks. Previously, Gregg Gilbert worked at TRUIST, DEUTSCHE BANK. Analyst's average stock valuation to be materialised ratio is 66.16% with an average time for price targets to be met of 284.16 days.
Most recent stock forecast was given on ATRS, Antares Pharma, Inc at 13-Apr-2022.
Gregg Gilbert best performing recommendations are on LCI (LANNETT COMPANY, INC).
The best stock recommendation documented was for LCI (LANNETT COMPANY, INC) at 8/29/2019. The price target of $40 was fulfilled within 1 day with a profit of $4.48 (12.61%) receiving and performance score of 126.13.
Average potential price target upside
Currently, out of the existing stock ratings of Gregg Gilbert - 22372 which are a Buy (67.95%), 10284 which are a Hold (31.24%), 267 which are a Sell (0.81%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
172
$13.75 (8.69%)
166
28 days ago
23/24 (95.83%)
$22.93 (27.45%)
344
Sell
153
$-5.25 (-3.32%)
135
1 months 19 days ago
20/20 (100%)
$19.5 (30.42%)
515
Buy
163
$4.75 (3.00%)
157
1 months 19 days ago
34/35 (97.14%)
$24.2 (28.52%)
414
Sell
153
$-5.25 (-3.32%)
92
1 months 19 days ago
6/6 (100%)
$25.57 (55.74%)
574
Hold
154
$-4.25 (-2.69%)
157
1 months 19 days ago
4/4 (100%)
$15.03 (18.69%)
198